Virgin Australia has been hit with a shareholder class action over representations made in a 2019 prospectus for a capital raising to fund its $700 million acquisition of the Velocity loyalty program, just six months before the airline sank into administration.
One Nation chief-of-staff James Ashby has failed to revive his lawsuit alleging the federal government breached the Fair Work Act by not paying his $4.5 million legal bill stemming from a dropped sexual harassment case against former House speaker Peter Slipper.
Former Bellamy’s Australia director Jan Cameron has consented to preserving up to $5.1 million in her Australian assets and not moving them offshore while proceedings she launched against the Australian Taxation Office are on foot.
Herbert Smith Freehills has partnered with the University of New South Wales on a practical training course for the firm’s Australian graduates that will allow them to start practicing sooner.
The nation’s peak body for barristers has lashed out at Prime Minister Scott Morrison for saying he has “never had much truck” with barristers during his political career and “didn’t care” if they disagreed with him about the need for a federal anti-corruption commission.
Moray & Agnew is facing a lawsuit by a former client who says the firm breached its duties by making an unauthorised $3.3 million transfer while representing him on an investment in a Melbourne storage facility development.
Pharmaceutical giant Pfizer has fired off a lawsuit against four drug companies for allegedly infringing one of its patents for biologic Enbrel by selling a biosimilar of the blockbuster arthritis drug in Australia.
The corporate regulator has taken Australian Mines to court after its managing director was allegedly caught lying at an investment conference about the value of an offtake agreement and funding for a project at its cobalt and nickel mine in Queensland.
Virgin Australia has struck back at a lawsuit by its former chief pilot alleging the airline sacked him for complaining of bullying and harassment by its CEO, saying it terminated the pilot’s employment after he was deemed medically unfit for his role.
Bayer has dropped its appeal to a ruling that quashed an extension for its patent covering an oral contraceptive, after the Full Court dealt drug makers a blow in two separate cases on how patent term extensions should be calculated.